RAPT THERAPEUTICS INC (RAPT)

US75382E1091 - Common Stock

1.08  +0.03 (+2.86%)

After market: 1.1 +0.02 (+1.85%)

Buy % Consensus

73

ChartMill assigns a Buy % Consensus number of 73% to RAPT. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 8.16. This target is 655.56% above the current price.
RAPT was analyzed by 17 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about RAPT.
In the previous month the buy percentage consensus was at a similar level.
RAPT was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 1.082.027.658.1617.85 - 87.04% 608.33% 655.56% 1,552.78%
Up and Down Grades
Date Firm Action Rating
2024-11-12 Wells Fargo Maintains Overweight -> Overweight
2024-11-12 HC Wainwright & Co. Reiterate Neutral
2024-11-11 JP Morgan Downgrade Neutral -> Underweight
2024-09-09 UBS Maintains Neutral -> Neutral
2024-08-20 HC Wainwright & Co. Reiterate Neutral
2024-07-23 HC Wainwright & Co. Reiterate Neutral
2024-05-14 Wolfe Research Downgrade Outperform -> Peer Perform
2024-05-10 Guggenheim Downgrade Buy -> Neutral
2024-05-10 Barclays Downgrade Overweight -> Equal-Weight
2024-04-10 HC Wainwright & Co. Reiterate Neutral
2024-03-27 JP Morgan Maintains Neutral -> Neutral
2024-02-22 UBS Downgrade Buy -> Neutral
2024-02-21 Leerink Partners Downgrade Outperform -> Market Perform
2024-02-21 Barclays Maintains Overweight -> Overweight
2024-02-21 JP Morgan Downgrade Overweight -> Neutral
2024-02-21 HC Wainwright & Co. Downgrade Buy -> Neutral
2024-02-20 Cantor Fitzgerald Downgrade Overweight -> Neutral
2024-02-16 Evercore ISI Group Initiate Outperform
2024-02-15 Wolfe Research Initiate Outperform
2023-11-30 JP Morgan Maintains Overweight -> Overweight
2023-11-15 HC Wainwright & Co. Reiterate Buy -> Buy
2023-09-14 Berenberg Initiate Buy
2023-08-16 JP Morgan Maintains Overweight -> Overweight
2023-08-14 Piper Sandler Maintains Overweight -> Overweight
2023-08-14 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-09 Stifel Initiate Buy
2023-06-15 Barclays Initiate Overweight
2023-06-05 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-12 HC Wainwright & Co. Maintains Buy -> Buy
2023-03-30 HC Wainwright & Co. Reiterate Buy